I was brought in to develop chromatin isolation protocols compatible with a novel microchip platform, including optimizing digestion and purification conditions for their specific chip chemistry. I also conducted application scoping to identify which scientific communities would find the most value in the technology and why.
Novel microchip technology platform company
Previous
Previous
Biotechnology company developing targeted drug delivery systems
Next
Next